Molybdenum Trioxide Nanocubes Aligned on a Graphene Oxide Substrate for the Detection of Norovirus by Surface-Enhanced Raman Scattering
| Autor: | Ojodomo J. Achadu, Enoch Y. Park, Fuyuki Abe, Tetsuro Suzuki |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Materials science
Surface Properties Nanotechnology 02 engineering and technology Biosensing Techniques Immunomagnetic separation Spectrum Analysis Raman 01 natural sciences Molybdenum trioxide law.invention symbols.namesake chemistry.chemical_compound law General Materials Science Particle Size Detection limit Molybdenum Graphene 010401 analytical chemistry Norovirus Substrate (chemistry) Oxides 021001 nanoscience & nanotechnology 0104 chemical sciences chemistry Linear range symbols Nanoparticles Graphite 0210 nano-technology Raman spectroscopy Biosensor |
| Zdroj: | ACS applied materialsinterfaces. 12(39) |
| ISSN: | 1944-8252 |
| Popis: | A novel biosensing system based on graphene-mediated surface-enhanced Raman scattering (G-SERS) using plasmonic/magnetic molybdenum trioxide nanocubes (mag-MoO3 NCs) has been designed to detect norovirus (NoV) via a dual SERS nanotag/substrate platform. A novel magnetic derivative of MoO3 NCs served as the SERS nanotag and the immunomagnetic separation material of the biosensor. Single-layer graphene oxide (SLGO) was adopted as the 2D SERS substrate/capture platform and acted as the signal reporter, with the ability to accommodate an additional Raman molecule as a coreporter. The developed SERS-based immunoassay achieved a signal amplification of up to ∼109-fold resulting from the combined electromagnetic and chemical mechanisms of the dual SERS nanotag/substrate system. The developed biosensor was employed for the detection of NoV in human fecal samples collected from infected patients by capturing the virus with the aid of NoV-specific antibody-functionalized magnetic MoO3 NCs. This approach enabled rapid signal amplification for NoV detection with this biosensing technology. The biosensor was tested and optimized using NoV-like particles within a broad linear range from 10 fg/mL to 100 ng/mL and a limit of detection (LOD) of ∼5.2 fg/mL. The practical applicability of the developed biosensor to detect clinical NoV subtypes in human fecal samples was demonstrated by effective detection with an LOD of ∼60 RNA copies/mL, which is ∼103-fold lower than that of a commercial enzyme-linked immunosorbent assay kit for NoV. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|